|
TERF2IP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.119830E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.588490E-02 |
| Normal-vs-Stage2 |
3.166600E-01 |
| Normal-vs-Stage3 |
2.501000E-01 |
| Normal-vs-Stage4 |
7.312500E-02 |
| Stage1-vs-Stage2 |
3.054400E-01 |
| Stage1-vs-Stage3 |
7.155200E-01 |
| Stage1-vs-Stage4 |
2.694000E-02 |
| Stage2-vs-Stage3 |
7.099600E-01 |
| Stage2-vs-Stage4 |
2.761900E-02 |
| Stage3-vs-Stage4 |
6.612100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.276800E-03 |
| Normal-vs-AfricanAmerican |
4.569600E-01 |
| Normal-vs-Asian |
3.073200E-01 |
| Caucasian-vs-AfricanAmerican |
4.144100E-02 |
| Caucasian-vs-Asian |
7.991000E-01 |
| AfricanAmerican-vs-Asian |
2.735600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.815100E-03 |
| Normal-vs-Female |
1.506620E-01 |
| Male-vs-Female |
4.303400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.173800E-01 |
| Normal-vs-Extreme_Weight |
9.483800E-03 |
| Normal-vs-Obese |
1.492150E-02 |
| Normal-vs-Extreme_Obese |
5.609400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.954200E-02 |
| Normal_Weight-vs-Obese |
5.787800E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.795800E-01 |
| Extreme_Weight-vs-Obese |
9.192400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.899000E-01 |
| Obese-vs-Extreme_Obese |
6.001200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.623400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.240240E-02 |
| Normal-vs-Age(61-80Yrs) |
2.860400E-02 |
| Normal-vs-Age(81-100Yrs) |
6.340200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.358400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.548800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.838400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.797600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.024600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.170400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.66990000000289E-05 |
| Normal-VS-Type2 PRCC |
4.927400E-01 |
| Normal-VS-KIRP CIMP |
7.462400E-01 |
| Normal-VS-Unclassified PRCC |
7.715800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.39270000004888E-06 |
| Type1 PRCC-VS-KIRP CIMP |
5.784000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.733210E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.054000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.234100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.856600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.169400E-01 |
| Normal-vs-N1 |
8.944200E-01 |
| Normal-vs-N2 |
5.820200E-01 |
| N0-vs-N1 |
4.531400E-01 |
| N0-vs-N2 |
5.887000E-01 |
| N1-vs-N2 |
6.050400E-01 |
|
|
